Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2025-12-25 @ 6:27 PM
Study NCT ID:
NCT00301366
Status:
COMPLETED
Last Update Posted:
2014-08-19
First Post:
2006-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
Sponsor:
Grifols Therapeutics LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-08
First Submit QC Date:
None
Study First Post Date:
2006-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-08-28
Results First Submit QC Date:
None
Results First Post Date:
2014-08-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-30
Last Update Post Date:
2014-08-19
Last Update Post Date Type:
ESTIMATED